ClinVar Miner

Submissions for variant NM_001164508.2(NEB):c.5971C>T (p.His1991Tyr)

gnomAD frequency: 0.06165  dbSNP: rs75807392
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
PreventionGenetics,PreventionGenetics RCV000117767 SCV000307374 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services,Illumina RCV000309553 SCV000416981 benign Nemaline myopathy 2 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
GeneDx RCV000117767 SCV000519522 benign not specified 2016-01-30 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Laboratory for Molecular Medicine,Mass General Brigham Personalized Medicine RCV000117767 SCV000711417 benign not specified 2014-11-26 criteria provided, single submitter clinical testing p.His1991Tyr in exon 47 of NEB: This variant is not expected to have clinical si gnificance because it has been identified in 5.4% (442/8180) of European America n chromosomes by the NHLBI Exome Sequencing Project ( u/EVS/) and in 26% (148/572) of Asian chromosomes by the 1000 Genomes Project (d bSNP rs75807392).
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000117767 SCV000917871 benign not specified 2017-09-25 criteria provided, single submitter clinical testing Variant summary: The NEB c.5971C>T (p.His1991Tyr) variant involves the alteration of a non-conserved nucleotide that is the first exonic nucleotide at an exon-intron junction. 4/4 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index) and 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 20328/251662 control chromosomes (1289 homozygotes) at a frequency of 0.080775, which is approximately 23 times the estimated maximal expected allele frequency of a pathogenic NEB variant (0.0035355), strongly suggesting this variant is likely a benign polymorphism. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. The variant of interest has not, to our knowledge, been reported in affected individuals via publications, nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign.
Invitae RCV000309553 SCV001716709 benign Nemaline myopathy 2 2021-12-19 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001542878 SCV001761274 benign Arthrogryposis multiplex congenita 6 2021-07-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000309553 SCV001761275 benign Nemaline myopathy 2 2021-07-10 criteria provided, single submitter clinical testing
Genetic Services Laboratory,University of Chicago RCV000117767 SCV000152024 likely benign not specified no assertion criteria provided clinical testing Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.
Natera, Inc. RCV000309553 SCV001453485 benign Nemaline myopathy 2 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.